193 related articles for article (PubMed ID: 31306827)
1. Innovative nanotechnologies for enhancing nucleic acids/gene therapy: Controlling intracellular trafficking to targeted biodistribution.
Nakamura T; Yamada Y; Sato Y; Khalil IA; Harashima H
Biomaterials; 2019 Oct; 218():119329. PubMed ID: 31306827
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional enveloped nanodevices (MENDs).
Sato Y; Nakamura T; Yamada Y; Akita H; Harashima H
Adv Genet; 2014; 88():139-204. PubMed ID: 25409606
[TBL] [Abstract][Full Text] [Related]
3. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
4. Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine.
Yamada Y; Sato Y; Nakamura T; Harashima H
J Control Release; 2020 Nov; 327():533-545. PubMed ID: 32916227
[TBL] [Abstract][Full Text] [Related]
5. Development of a multifunctional envelope-type nano device and its application to nanomedicine.
Sato Y; Nakamura T; Yamada Y; Harashima H
J Control Release; 2016 Dec; 244(Pt B):194-204. PubMed ID: 27374187
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional envelope-type nano device for controlled intracellular trafficking and selective targeting in vivo.
Kajimoto K; Sato Y; Nakamura T; Yamada Y; Harashima H
J Control Release; 2014 Sep; 190():593-606. PubMed ID: 24794902
[TBL] [Abstract][Full Text] [Related]
7. Innovative Technologies in Nanomedicines: From Passive Targeting to Active Targeting/From Controlled Pharmacokinetics to Controlled Intracellular Pharmacokinetics.
Sato Y; Sakurai Y; Kajimoto K; Nakamura T; Yamada Y; Akita H; Harashima H
Macromol Biosci; 2017 Jan; 17(1):. PubMed ID: 27797146
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System.
Hayashi Y; Hatakeyama H; Kajimoto K; Hyodo M; Akita H; Harashima H
Bioconjug Chem; 2015 Jul; 26(7):1266-76. PubMed ID: 25938819
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system.
Kogure K; Akita H; Yamada Y; Harashima H
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):559-71. PubMed ID: 18037529
[TBL] [Abstract][Full Text] [Related]
10. [Development of various multifunctional envelope-type nano device MEND based on novel assembly technologies].
Kogure K; Akita H; Harashima H
Yakugaku Zasshi; 2008 Feb; 128(2):219-32. PubMed ID: 18239369
[TBL] [Abstract][Full Text] [Related]
11. The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS.
Sato Y; Nakamura T; Yamada Y; Harashima H
J Control Release; 2021 Feb; 330():305-316. PubMed ID: 33358975
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
13. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
14. Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.
Sakurai Y; Matsuda T; Hada T; Harashima H
Biol Pharm Bull; 2015; 38(8):1185-91. PubMed ID: 26235581
[TBL] [Abstract][Full Text] [Related]
15. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
16. Efficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano device.
Suzuki R; Yamada Y; Harashima H
Biol Pharm Bull; 2007 Apr; 30(4):758-62. PubMed ID: 17409516
[TBL] [Abstract][Full Text] [Related]
17. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery.
Yamada Y; Furukawa R; Yasuzaki Y; Harashima H
Mol Ther; 2011 Aug; 19(8):1449-56. PubMed ID: 21694702
[TBL] [Abstract][Full Text] [Related]
18. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
19. Functional improvement of an IRQ-PEG-MEND for delivering genes to the lung.
Ishitsuka T; Akita H; Harashima H
J Control Release; 2011 Aug; 154(1):77-83. PubMed ID: 21619903
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]